The University of Alabama at Birmingham (UAB) School of Medicine (SOM) is recruiting up to 12 investigators as part of a major strategic initiative in the Neurosciences, to build on a strong portfolio across basic and translational research. Recruitment is for tenured, tenure-track, and non-tenure-earning faculty at all ranks and includes academic appointment in one or more of 27 academic departments across the SOM, many of which rank in the top 10 nationally in NIH funding. All applications will be considered, but priority will be given to those with dynamic research programs focused on: neurodevelopment and neurodevelopmental disorders, neurodegenerative disorders including Alzheimer disease and Parkinson disease, aging and brain health, neuroinflammation, addiction, neuroimaging, precision medicine including gene therapy and human induced pluripotent stem cells, and gut/brain interactions.
Driven by an intensely collaborative and entrepreneurial character, UAB is one of the leading economic engines of the State, with a nearly $4 billion budget and a statewide economic impact exceeding $7 billion annually. UAB is Alabama’s largest employer with more than 23,000 employees; it supports more than 64,000 jobs statewide. With more than 1,300 full time faculty and almost 1,200 medical and graduate students, the UAB SOM ranks 23rd nationally in NIH research funding and in the top 10 for all public institutions. Total research expenditures at UAB exceeded $538 million in 2017.
Successful applicants will join one of the strongest neuroscience environments in the country. The UAB Comprehensive Neuroscience Center (CNC) has more than 450 neuroscience research faculty, clinicians, staff, students & trainees representing 23 UAB departments across 7 UAB schools and spanning a diverse range of neuroscience research areas. Several centers and institutes at UAB focus on the specific areas of interest, including the Civitan International Research Center (CIRC), Center for Neurodegeneration and Experimental Therapeutics (CNET), Alzheimer’s Disease Center, Evelyn F. McKnight Brain Institute, Multiple Sclerosis Center, Civitan International Neuroimaging Laboratory, Advanced Imaging Facility, and Hugh Kaul Precision Medicine Institute. UAB is one of 42 institutions with an NIH Clinical and Translational Science Award, which supports translational research and creates a supportive environment that promotes junior investigators.
The scientists recruited through this initiative are expected to establish outstanding, independent academic programs supporting all of the core missions of the University: research, education, and service. They will work individually and collaboratively to undertake innovative scientific discovery, grow extramural funding, engage in and promote education of learners at all levels, and support the critical service missions of the University in delivering and improving health care.
Applicants must upload their Curriculum Vitae, one page letter of interest, and 3 professional references to (http://uab.peopleadmin.com/postings/4719). Application deadline is March 31, 2019. Review of applications will continue until all positions are filled. Applicants must have an MD, PhD, or MD/PhD. Selected applicants will join a diverse and vibrant academic community that values and is committed to diversity, equity, and inclusion and must be able to work in a team environment.
UAB is an Equal Opportunity/Affirmative Action Employer committed to fostering a diverse, equitable and family?friendly environment in which all faculty and staff can excel and achieve work/life balance irrespective of, race, national origin, age, genetic or family medical history, gender, faith, gender identity and expression as well as sexual orientation. UAB also encourages applications from individuals with disabilities and veterans.
A pre-employment background investigation is performed on candidates selected for employment. In addition, physicians and other clinical faculty candidates who will be employed by the University of Alabama Health Services Foundation (UAHSF) or other UAB Medicine entities, must successfully complete a pre-employment drug and nicotine screen to be hired.